Stoke Therapeutics
STOK
STOK
92 hedge funds and large institutions have $556M invested in Stoke Therapeutics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
36% less capital invested
Capital invested by funds: $871M → $556M (-$315M)
Holders
92
Holding in Top 10
3
Calls
$514K
Puts
$3K
Top Buyers
| 1 | +$6.89M | |
| 2 | +$6.82M | |
| 3 | +$3.7M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.62M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.5M |
Top Sellers
| 1 | -$7.56M | |
| 2 | -$6.68M | |
| 3 | -$5.62M | |
| 4 |
SG Americas Securities
New York
|
-$3.84M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.77M |